Skip to main content
Caplight Logo









Midland Pharmaceuticals

Midland Pharmaceuticals

Private
LondonHealthcare & Life Scienceshttps://midlandpharmaceuticals.com/

Last Round

Seed

May 21, 2024

Company Overview

Midland Pharmaceuticals is a clinical-stage pharmaceutical company developing novel therapeutics for neurodegenerative disorders, specifically focusing on spinal cord injury and ischemic stroke.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoveryneurodegenerative disordersspinal cord injuryischemic strokeclinical trialsmatrix metalloproteinase inhibitorMMP inhibitorbiotech startuptherapeutic developmentsmall molecule therapeuticsdrug pipelinepharmaceutical researchneuroscience

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Midland Pharmaceuticals Comparables

Compare Midland Pharmaceuticals with similar companies based on industry and business-model similarity.

Midland Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioAxone BioSciences
79%
Astrocyte Pharmaceuticals Inc.
79%
Axonis Therapeutics
78%

Midland Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 21, 2024

Midland Pharmaceuticals Investors

Notable investors and investment history

Midland Pharmaceuticals investors
InvestorRounds
The University of SheffieldSeed
NLC Health VenturesSeed
University of BirminghamSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 21, 2024

    Led by NLC Health Ventures with participation from The University of Sheffield and University of Birmingham.

Midland Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Midland Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Midland Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Year Founded2024
Last FundingMay 21, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?